共 203 条
[1]
Sy CL(2022)Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms J Microbiol Immunol Infect 55 359-386
[2]
Chen PY(2016)Comparison of the pharmacokinetics of vancomycin in neurosurgical and non-neurosurgical patients Int J Antimicrob Agents 48 381-387
[3]
Cheng CW(2011)Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary Clin Infect Dis 52 285-292
[4]
Huang LJ(2016)Vancomycin and the risk of AKI: a systematic review and meta-analysis Clin J Am Soc Nephrol 11 2132-2140
[5]
Wang CH(2020)Acute kidney injury in Asia: disease burden Semin Nephrol 40 443-455
[6]
Chang TH(2013)Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter Antimicrob Agents Chemother 57 734-744
[7]
Chang YC(2022)Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis Br J Clin Pharmacol 88 3977-3989
[8]
Chang CJ(2015)A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury Am J Kidney Dis 66 602-612
[9]
Hii IM(2020)Vancomycin serum concentration after 48 h of administration: a 3-years survey in an intensive care unit Antibiotics (Basel) 9 793-1348
[10]
Hsu YL(2018)Acute kidney injury epidemiology, risk factors, and outcomes in critically ill patients 16–25 years of age treated in an adult intensive care unit Ann Intensive Care 8 26-1091